Skip to content

Ultra Sound Guided Genicular Nerves Cooled Radiofrequency Ablation in Total Knee Replacement Surgeries

Ultra Sound Guided Genicular Nerves Cooled Radiofrequency Ablation in Total Knee Replacement Surgeries

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06651762
Enrollment
66
Registered
2024-10-22
Start date
2024-10-14
Completion date
2026-01-25
Last updated
2026-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis of Knee

Brief summary

Total Knee Replacement surgery is common procedure that is usually done for patients suffering from persistent pain with limitation of movement. Unfortunately, they do suffer after the operation as it is associated still with significant pain that affect the rehabilitation plan, hospital length of stay, life style and patient satisfaction. New approaches are rising every day to add to the multimodal management plan. Genicular nerves cooled radiofrequency ablation is a new approach that can be simply done U.S. guided with little side effects, if any, and great results.

Detailed description

the study measures the efficacy of genicular nerves cooled radiofrequency ablation in enhancing quality of rehabilitation in patients undergoing total knee replacement

Interventions

PROCEDUREunilateral Radiofrequency

unilateral genicular nerve cooled radio frequency ablation pre-operative

PROCEDUREbilateral Radiofrequency

bilateral genicular nerve cooled radio frequency ablation pre-operative

PROCEDUREEpidural

Patients will receive epidural anesthesia intra operative and epidural analgesia post-operative

Sponsors

Ain Shams University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

• Undergoing a scheduled unilateral total knee replacement surgery \-

Exclusion criteria

* • Allergy to any of the drugs used in the study * Alcohol or drug abuse * Psychiatric disease

Design outcomes

Primary

MeasureTime frameDescription
o Epidural rescue doses1st 48 hoursrescue doses reflects degree of pain control

Secondary

MeasureTime frameDescription
WOMAC scorebaseline preoperative, and the at 2, 6 and 12 weeks postoperativeassessment of the functional state of the patient and degree of pain and limitation of movement
Knee range of motionAssessed weekly for 3 weeks postoperatively (Weeks 1, 2, and 3)Time to achieve full knee range of motion will be assessed by measuring active knee flexion and extension in degrees (°) using a universal goniometer during weekly postoperative assessments. The outcome will be reported as the number of days or weeks required to achieve full range of motion, as defined in the study protocol.
Postoperative inflammatory signs assessed by clinical examinationAssessed weekly for 3 weeks postoperatively (Weeks 1, 2, and 3).Postoperative inflammatory signs, including redness (erythema), local warmth, and swelling around the operated knee, will be assessed by clinical examination. Each sign will be recorded as present or absent. The outcome will be reported as the number of participants with each inflammatory sign at each assessment.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 6, 2026